Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Immunotherapy market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Immunotherapy market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Immunotherapy market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Immunotherapy products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Immunotherapy products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Immunotherapy market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Immunotherapy development has been the leading industry trend of Immunotherapy market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Immunotherapy Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Monoclonal Antibodies, Therapeutic Vaccines, Checkpoint Inhibitors, Non-Specific Immunotherapy |
| By Application Outlook |
Oncology, Inflammation, Central Nervous System, Others |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Abbvie, Amgen, Inc., Biogen, Bristol-Myers Squibb, Celgene, Johnson & Johnson, Merck, Novartis, Pfizer, Roche |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Abbvie
- Amgen
- Inc.
- Biogen
- Bristol-Myers Squibb
- Celgene
- Johnson & Johnson
- Merck
- Novartis
- Pfizer
- Roche
IMMUNOTHERAPY Market, By Type
- Monoclonal Antibodies
- Therapeutic Vaccines
- Checkpoint Inhibitors
- Non-Specific Immunotherapy
IMMUNOTHERAPYMarket, By Application
- Oncology
- Inflammation
- Central Nervous System
- Others
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Immunotherapy Market Overview
1.1 Immunotherapy Product Overview
1.2 Immunotherapy Market Segment by Type
1.2.1 Monoclonal Antibodies
1.2.2 Therapeutic Vaccines
1.2.3 Checkpoint Inhibitors
1.2.4 Non-Specific Immunotherapy
1.3 Global Immunotherapy Market Size by Type
1.3.1 Global Immunotherapy Sales and Growth by Type
1.3.2 Global Immunotherapy Sales and Market Share by Type (2014-2019)
1.3.3 Global Immunotherapy Revenue and Market Share by Type (2014-2019)
1.3.4 Global Immunotherapy Price by Type (2014-2019)
2 Global Immunotherapy Market Competition by Company
2.1 Global Immunotherapy Sales and Market Share by Company (2014-2019)
2.2 Global Immunotherapy Revenue and Share by Company (2014-2019)
2.3 Global Immunotherapy Price by Company (2014-2019)
2.4 Global Top Players Immunotherapy Manufacturing Base Distribution, Sales Area, Product Types
2.5 Immunotherapy Market Competitive Situation and Trends
2.5.1 Immunotherapy Market Concentration Rate
2.5.2 Global Immunotherapy Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Immunotherapy Company Profiles and Sales Data
3.1 Abbvie
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Immunotherapy Product Category, Application and Specification
3.1.3 Abbvie Immunotherapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Amgen, Inc.
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Immunotherapy Product Category, Application and Specification
3.2.3 Amgen, Inc. Immunotherapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Biogen
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Immunotherapy Product Category, Application and Specification
3.3.3 Biogen Immunotherapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Bristol-Myers Squibb
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Immunotherapy Product Category, Application and Specification
3.4.3 Bristol-Myers Squibb Immunotherapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Celgene
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Immunotherapy Product Category, Application and Specification
3.5.3 Celgene Immunotherapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Johnson & Johnson
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Immunotherapy Product Category, Application and Specification
3.6.3 Johnson & Johnson Immunotherapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Merck
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Immunotherapy Product Category, Application and Specification
3.7.3 Merck Immunotherapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Novartis
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Immunotherapy Product Category, Application and Specification
3.8.3 Novartis Immunotherapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Pfizer
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Immunotherapy Product Category, Application and Specification
3.9.3 Pfizer Immunotherapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 Roche
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Immunotherapy Product Category, Application and Specification
3.10.3 Roche Immunotherapy Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
4 Immunotherapy Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Immunotherapy Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Immunotherapy Sales and Revenue by Regions
4.2.1 Global Immunotherapy Sales and Market Share by Regions (2014-2019)
4.2.2 Global Immunotherapy Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Immunotherapy Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Immunotherapy Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Immunotherapy Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Immunotherapy Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Immunotherapy Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Immunotherapy Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Immunotherapy Application/End Users
5.1 Immunotherapy Segment by Application
5.1.1 Oncology
5.1.2 Inflammation
5.1.3 Central Nervous System
5.1.4 Others
5.2 Global Immunotherapy Product Segment by Application
5.2.1 Global Immunotherapy Sales by Application
5.2.2 Global Immunotherapy Sales and Market Share by Application (2014-2019)
6 Global Immunotherapy Market Forecast
6.1 Global Immunotherapy Sales, Revenue Forecast (2019-2025)
6.1.1 Global Immunotherapy Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Immunotherapy Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Immunotherapy Forecast by Regions
6.2.1 North America Immunotherapy Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Immunotherapy Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Immunotherapy Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Immunotherapy Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Immunotherapy Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Immunotherapy Forecast by Type
6.3.1 Global Immunotherapy Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Monoclonal Antibodies Gowth Forecast
6.3.3 Therapeutic Vaccines Gowth Forecast
6.4 Immunotherapy Forecast by Application
6.4.1 Global Immunotherapy Sales Forecast by Application (2019-2025)
6.4.2 Global Immunotherapy Forecast in Oncology
6.4.3 Global Immunotherapy Forecast in Inflammation
7 Immunotherapy Upstream Raw Materials
7.1 Immunotherapy Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Immunotherapy Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
